We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for lorlatinib (Pfizer Australia Pty Ltd)
Active ingredients
lorlatinib
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Oncology